Total Funding
55
29
Total FundingCorporate Round raised
Growth Score
-5 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
86701
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Acquired by 
Vividion Therapeutics
- Greg Mossinghoff: Co-Founder and Chief Business Officer
Kris Wood: Co-FounderPast Role: Duke University, Assistant Professor
About the Company
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
The company was founded in 2019 and based in Durham, North Carolina.
